Delivering innovation and improvement across West Yorkshire and Harrogate
People with diabetes, long term conditions and those with heart disease will be among the first to benefit from a major new drive to modernise the delivery of health and social care across West Yorkshire and Harrogate.
Working in partnership with Yorkshire & Humber Academic Health Science Network, West Yorkshire and Harrogate Health and Care Partnership will be applying the latest evidence and newest technology to improve people’s health across a number of areas, including:
Treating 89% of patients with atrial fibrillation (AF), which is about detecting and treating people who are at risk of stroke so that around 9 in 10 people with AF are managed by GPs using the best local treatments available. This will prevent 190 strokes over three years. This involves working with 80 GP practices initially and those where there is the greatest opportunity to make a difference first.
The Partnership is also looking at hypertension improvement programme, this could potentially prevent up to 420 heart attacks within three years. If approved, this will be done through identifying and treating people with hypertension who are not yet diagnosed. Hypertension increases risk of serious problems such as heart attacks and stroke.
The Partnership is also looking at improvement in the management of cholesterol, which will help reduce the possibility of heart attack and other CVD events. This will be done through making the most of statin treatment which lowers the level of cholesterol in your blood for those diagnosed.
The partnership also aims to improve care for people with diabetes. This is important because people with diabetes are at high risk of developing CVD. This work will be developed with doctors and patients to achieve good glycaemic control, which helps to reduce the complications associated with diabetes.
- The programme has the potential to prevent around 2,000 cardiovascular events, including heart attacks and heart disease over five years. The work will involve identifying and treating people with a high or very high risk of developing CVD.